The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Animal Softgel Capsules Market Outlook 2024
Synopsis
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
The global Non-Animal Softgel Capsules market was valued at US$ 517 million in 2020 and is expected to reach US$ 839.3 million by the end of 2027, growing at a CAGR of 7.2% during 2021-2027.
This report focuses on Non-Animal Softgel Capsules volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Non-Animal Softgel Capsules market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Non-Animal Softgel Capsules Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segment by Application
Health Supplements
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.
Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.
Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.
This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
The global Non-Animal Softgel Capsules market was valued at US$ 517 million in 2020 and is expected to reach US$ 839.3 million by the end of 2027, growing at a CAGR of 7.2% during 2021-2027.
This report focuses on Non-Animal Softgel Capsules volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Non-Animal Softgel Capsules market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Non-Animal Softgel Capsules Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Plant Polysaccharides Softgel Capsules
Starch Softgel Capsules
Segment by Application
Health Supplements
Pharmaceutical
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Catalent
Procaps Laboratorios
EuroCaps
Best Formulations
Aenova
Captek
Sirio
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Index1 Non-Animal Softgel Capsules Market Overview
1.1 Product Overview and Scope of Non-Animal Softgel Capsules
1.2 Non-Animal Softgel Capsules Segment by Type
1.2.1 Global Non-Animal Softgel Capsules Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Plant Polysaccharides Softgel Capsules
1.2.3 Starch Softgel Capsules
1.3 Non-Animal Softgel Capsules Segment by Application
1.3.1 Global Non-Animal Softgel Capsules Sales Comparison by Application: (2021-2027)
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts
1.4.1 Global Non-Animal Softgel Capsules Revenue 2016-2027
1.4.2 Global Non-Animal Softgel Capsules Sales 2016-2027
1.4.3 Non-Animal Softgel Capsules Market Size by Region: 2016 Versus 2021 Versus 2027
2 Non-Animal Softgel Capsules Market Competition by Manufacturers
2.1 Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-Animal Softgel Capsules Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-Animal Softgel Capsules Manufacturing Sites, Area Served, Product Type
2.5 Non-Animal Softgel Capsules Market Competitive Situation and Trends
2.5.1 Non-Animal Softgel Capsules Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-Animal Softgel Capsules Players Market Share by Revenue
2.5.3 Global Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Animal Softgel Capsules Retrospective Market Scenario by Region
3.1 Global Non-Animal Softgel Capsules Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Non-Animal Softgel Capsules Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.3.1 North America Non-Animal Softgel Capsules Sales by Country
3.3.2 North America Non-Animal Softgel Capsules Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Non-Animal Softgel Capsules Market Facts & Figures by Country
3.4.1 Europe Non-Animal Softgel Capsules Sales by Country
3.4.2 Europe Non-Animal Softgel Capsules Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-Animal Softgel Capsules Market Facts & Figures by Region
3.5.1 Asia Pacific Non-Animal Softgel Capsules Sales by Region
3.5.2 Asia Pacific Non-Animal Softgel Capsules Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Non-Animal Softgel Capsules Market Facts & Figures by Country
3.6.1 Latin America Non-Animal Softgel Capsules Sales by Country
3.6.2 Latin America Non-Animal Softgel Capsules Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-Animal Softgel Capsules Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-Animal Softgel Capsules Sales by Country
3.7.2 Middle East and Africa Non-Animal Softgel Capsules Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-Animal Softgel Capsules Historic Market Analysis by Type
4.1 Global Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)
4.2 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2016-2021)
4.3 Global Non-Animal Softgel Capsules Price by Type (2016-2021)
5 Global Non-Animal Softgel Capsules Historic Market Analysis by Application
5.1 Global Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)
5.2 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2016-2021)
5.3 Global Non-Animal Softgel Capsules Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Catalent
6.1.1 Catalent Corporation Information
6.1.2 Catalent Description and Business Overview
6.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Catalent Non-Animal Softgel Capsules Product Portfolio
6.1.5 Catalent Recent Developments/Updates
6.2 Procaps Laboratorios
6.2.1 Procaps Laboratorios Corporation Information
6.2.2 Procaps Laboratorios Description and Business Overview
6.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
6.2.5 Procaps Laboratorios Recent Developments/Updates
6.3 EuroCaps
6.3.1 EuroCaps Corporation Information
6.3.2 EuroCaps Description and Business Overview
6.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.3.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
6.3.5 EuroCaps Recent Developments/Updates
6.4 Best Formulations
6.4.1 Best Formulations Corporation Information
6.4.2 Best Formulations Description and Business Overview
6.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Best Formulations Non-Animal Softgel Capsules Product Portfolio
6.4.5 Best Formulations Recent Developments/Updates
6.5 Aenova
6.5.1 Aenova Corporation Information
6.5.2 Aenova Description and Business Overview
6.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Aenova Non-Animal Softgel Capsules Product Portfolio
6.5.5 Aenova Recent Developments/Updates
6.6 Captek
6.6.1 Captek Corporation Information
6.6.2 Captek Description and Business Overview
6.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Captek Non-Animal Softgel Capsules Product Portfolio
6.6.5 Captek Recent Developments/Updates
6.7 Sirio
6.6.1 Sirio Corporation Information
6.6.2 Sirio Description and Business Overview
6.6.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sirio Non-Animal Softgel Capsules Product Portfolio
6.7.5 Sirio Recent Developments/Updates
6.8 Bahrain Pharma
6.8.1 Bahrain Pharma Corporation Information
6.8.2 Bahrain Pharma Description and Business Overview
6.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
6.8.5 Bahrain Pharma Recent Developments/Updates
6.9 Robinson Pharma
6.9.1 Robinson Pharma Corporation Information
6.9.2 Robinson Pharma Description and Business Overview
6.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
6.9.5 Robinson Pharma Recent Developments/Updates
6.10 Aland
6.10.1 Aland Corporation Information
6.10.2 Aland Description and Business Overview
6.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Aland Non-Animal Softgel Capsules Product Portfolio
6.10.5 Aland Recent Developments/Updates
6.11 Fuji Capsule
6.11.1 Fuji Capsule Corporation Information
6.11.2 Fuji Capsule Non-Animal Softgel Capsules Description and Business Overview
6.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
6.11.5 Fuji Capsule Recent Developments/Updates
6.12 Sunsho Pharmaceutical
6.12.1 Sunsho Pharmaceutical Corporation Information
6.12.2 Sunsho Pharmaceutical Non-Animal Softgel Capsules Description and Business Overview
6.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
6.12.5 Sunsho Pharmaceutical Recent Developments/Updates
6.13 Erkang
6.13.1 Erkang Corporation Information
6.13.2 Erkang Non-Animal Softgel Capsules Description and Business Overview
6.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Erkang Non-Animal Softgel Capsules Product Portfolio
6.13.5 Erkang Recent Developments/Updates
7 Non-Animal Softgel Capsules Manufacturing Cost Analysis
7.1 Non-Animal Softgel Capsules Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-Animal Softgel Capsules
7.4 Non-Animal Softgel Capsules Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-Animal Softgel Capsules Distributors List
8.3 Non-Animal Softgel Capsules Customers
9 Non-Animal Softgel Capsules Market Dynamics
9.1 Non-Animal Softgel Capsules Industry Trends
9.2 Non-Animal Softgel Capsules Growth Drivers
9.3 Non-Animal Softgel Capsules Market Challenges
9.4 Non-Animal Softgel Capsules Market Restraints
10 Global Market Forecast
10.1 Non-Animal Softgel Capsules Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Type (2022-2027)
10.2 Non-Animal Softgel Capsules Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Application (2022-2027)
10.3 Non-Animal Softgel Capsules Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Non-Animal Softgel Capsules Sales (M Capsules) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-Animal Softgel Capsules Sales (M Capsules) Comparison by Application (2021-2027)
Table 3. Global Non-Animal Softgel Capsules Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-Animal Softgel Capsules Covered in This Study
Table 5. Global Non-Animal Softgel Capsules Sales (M Capsules) of Key Manufacturers (2016-2021)
Table 6. Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Non-Animal Softgel Capsules Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-Animal Softgel Capsules Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-Animal Softgel Capsules Average Price (US$/Capsule) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-Animal Softgel Capsules Manufacturing Sites and Area Served
Table 11. Manufacturers Non-Animal Softgel Capsules Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-Animal Softgel Capsules by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Animal Softgel Capsules as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-Animal Softgel Capsules Sales by Region (2016-2021) & (M Capsules)
Table 16. Global Non-Animal Softgel Capsules Sales Market Share by Region (2016-2021)
Table 17. Global Non-Animal Softgel Capsules Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)
Table 19. North America Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)
Table 20. North America Non-Animal Softgel Capsules Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)
Table 23. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)
Table 24. Europe Non-Animal Softgel Capsules Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-Animal Softgel Capsules Sales by Region (2016-2021) & (M Capsules)
Table 27. Asia Pacific Non-Animal Softgel Capsules Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-Animal Softgel Capsules Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-Animal Softgel Capsules Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)
Table 31. Latin America Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-Animal Softgel Capsules Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)
Table 35. Middle East and Africa Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-Animal Softgel Capsules Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)
Table 38. Global Non-Animal Softgel Capsules Sales (M Capsules) by Type (2016-2021)
Table 39. Global Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)
Table 40. Global Non-Animal Softgel Capsules Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-Animal Softgel Capsules Revenue Share by Type (2016-2021)
Table 42. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Type (2016-2021)
Table 43. Global Non-Animal Softgel Capsules Sales (M Capsules) by Application (2016-2021)
Table 44. Global Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)
Table 45. Global Non-Animal Softgel Capsules Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-Animal Softgel Capsules Revenue Share by Application (2016-2021)
Table 47. Global Non-Animal Softgel Capsules Price (US$/Capsule) by Application (2016-2021)
Table 48. Catalent Corporation Information
Table 49. Catalent Description and Business Overview
Table 50. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 51. Catalent Non-Animal Softgel Capsules Product
Table 52. Catalent Recent Developments/Updates
Table 53. Procaps Laboratorios Corporation Information
Table 54. Procaps Laboratorios Description and Business Overview
Table 55. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 56. Procaps Laboratorios Non-Animal Softgel Capsules Product
Table 57. Procaps Laboratorios Recent Developments/Updates
Table 58. EuroCaps Corporation Information
Table 59. EuroCaps Description and Business Overview
Table 60. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 61. EuroCaps Non-Animal Softgel Capsules Product
Table 62. EuroCaps Recent Developments/Updates
Table 63. Best Formulations Corporation Information
Table 64. Best Formulations Description and Business Overview
Table 65. Best Formulations Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 66. Best Formulations Non-Animal Softgel Capsules Product
Table 67. Best Formulations Recent Developments/Updates
Table 68. Aenova Corporation Information
Table 69. Aenova Description and Business Overview
Table 70. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 71. Aenova Non-Animal Softgel Capsules Product
Table 72. Aenova Recent Developments/Updates
Table 73. Captek Corporation Information
Table 74. Captek Description and Business Overview
Table 75. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 76. Captek Non-Animal Softgel Capsules Product
Table 77. Captek Recent Developments/Updates
Table 78. Sirio Corporation Information
Table 79. Sirio Description and Business Overview
Table 80. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 81. Sirio Non-Animal Softgel Capsules Product
Table 82. Sirio Recent Developments/Updates
Table 83. Bahrain Pharma Corporation Information
Table 84. Bahrain Pharma Description and Business Overview
Table 85. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 86. Bahrain Pharma Non-Animal Softgel Capsules Product
Table 87. Bahrain Pharma Recent Developments/Updates
Table 88. Robinson Pharma Corporation Information
Table 89. Robinson Pharma Description and Business Overview
Table 90. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 91. Robinson Pharma Non-Animal Softgel Capsules Product
Table 92. Robinson Pharma Recent Developments/Updates
Table 93. Aland Corporation Information
Table 94. Aland Description and Business Overview
Table 95. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 96. Aland Non-Animal Softgel Capsules Product
Table 97. Aland Recent Developments/Updates
Table 98. Fuji Capsule Corporation Information
Table 99. Fuji Capsule Description and Business Overview
Table 100. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 101. Fuji Capsule Non-Animal Softgel Capsules Product
Table 102. Fuji Capsule Recent Developments/Updates
Table 103. Sunsho Pharmaceutical Corporation Information
Table 104. Sunsho Pharmaceutical Description and Business Overview
Table 105. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 106. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product
Table 107. Sunsho Pharmaceutical Recent Developments/Updates
Table 108. Erkang Corporation Information
Table 109. Erkang Description and Business Overview
Table 110. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue (Million US$), Price (US$/Capsule) and Gross Margin (2016-2021)
Table 111. Erkang Non-Animal Softgel Capsules Product
Table 112. Erkang Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Non-Animal Softgel Capsules Distributors List
Table 116. Non-Animal Softgel Capsules Customers List
Table 117. Non-Animal Softgel Capsules Market Trends
Table 118. Non-Animal Softgel Capsules Growth Drivers
Table 119. Non-Animal Softgel Capsules Market Challenges
Table 120. Non-Animal Softgel Capsules Market Restraints
Table 121. Global Non-Animal Softgel Capsules Sales Forecast by Type (2022-2027) & (M Capsules)
Table 122. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Non-Animal Softgel Capsules Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Non-Animal Softgel Capsules Sales Forecast by Application (2022-2027) & (M Capsules)
Table 126. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Non-Animal Softgel Capsules Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Non-Animal Softgel Capsules Sales Forecast by Region (2022-2027) & (M Capsules)
Table 130. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Non-Animal Softgel Capsules Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-Animal Softgel Capsules
Figure 2. Global Non-Animal Softgel Capsules Market Share by Type in 2020 & 2027
Figure 3. Plant Polysaccharides Softgel Capsules Product Picture
Figure 4. Starch Softgel Capsules Product Picture
Figure 5. Global Non-Animal Softgel Capsules Market Share by Application in 2020 & 2027
Figure 6. Health Supplements
Figure 7. Pharmaceutical
Figure 8. Others
Figure 9. Global Non-Animal Softgel Capsules Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Non-Animal Softgel Capsules Market Size 2016-2027 (US$ Million)
Figure 11. Global Non-Animal Softgel Capsules Sales 2016-2027 (M Capsules)
Figure 12. Global Non-Animal Softgel Capsules Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Non-Animal Softgel Capsules Sales Share by Manufacturers in 2020
Figure 14. Global Non-Animal Softgel Capsules Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Non-Animal Softgel Capsules Players: Market Share by Revenue in 2020
Figure 16. Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Non-Animal Softgel Capsules Sales Market Share by Region (2016-2021)
Figure 18. Global Non-Animal Softgel Capsules Sales Market Share by Region in 2020
Figure 19. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2016-2021)
Figure 20. Global Non-Animal Softgel Capsules Revenue Market Share by Region in 2020
Figure 21. United States Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Non-Animal Softgel Capsules Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Non-Animal Softgel Capsules by Type (2016-2021)
Figure 44. Sales Market Share of Non-Animal Softgel Capsules by Application (2016-2021)
Figure 45. Sales Market Share of Non-Animal Softgel Capsules by Application in 2020
Figure 46. Revenue Share of Non-Animal Softgel Capsules by Application (2016-2021)
Figure 47. Revenue Share of Non-Animal Softgel Capsules by Application in 2020
Figure 48. Manufacturing Cost Structure of Non-Animal Softgel Capsules
Figure 49. Manufacturing Process Analysis of Non-Animal Softgel Capsules
Figure 50. Non-Animal Softgel Capsules Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
